Most cited papers from Instituto Alexander Fleming

The most cited paper from Instituto Alexander Fleming is "Erlotinib in Previously Treated Non–Small-Cell Lung Cancer" (Frances Alice Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al., 2005), with 5,471 citations. Next come "First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial" (1,396) and "Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up" (671).

Showing 50 of 60 papers. Every paper with more than 58 citations is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.